Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Colgate-Palmolive Files Quarterly Report on Form 10-Q

25th Nov 2009 15:05

Colgate-Palmolive Company (LSE: CLG) today confirmed that it has sent its Quarterly Report on Form 10-Q for the quarter ended September 30, 2009, which was filed with the U.S. Securities and Exchange Commission ("SEC") on October 29, 2009, to the UK Listing Authority in connection with the Company's UK listing. The document will shortly be available for inspection at the UK Listing Authority's Document Viewing Facility, which is located at:

Financial Services Authority25 The North Colonnade, Canary WharfLondon E14 6HS

This document is also available in the For Investors section of Colgate-Palmolive Company's website at http://www.colgate.com. Colgate-Palmolive Company makes available free of charge on its website, http://www.colgate.com, its Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, reports filed pursuant to Section 16 of the U.S. Securities Exchange Act of 1934 and amendments to those reports as soon as reasonably practicable after the documents are electronically filed with or furnished to the SEC. All of these documents will be provided free of charge to any shareholder requesting a copy by writing to: Colgate-Palmolive Company, 300 Park Avenue, New York, New York, 10022, USA, Attention: Investor Relations. These documents are also available on the SEC's website at http://www.sec.gov.

* * *

About Colgate-Palmolive: Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Mennen, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, Elmex, Tom's of Maine, Ajax, Axion, Fabuloso, Soupline, and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. For more information about Colgate's global business, visit the Company's web site at http://www.colgate.com.

The materials referred to in this press release may contain forward-looking statements. Investors should consult the Company's filings with the Securities and Exchange Commission (including the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2008) for information about certain factors that could cause differences from these statements. Copies of these filings may be obtained upon request from the Company's Investor Relations Department or the Company's web site at http://www.colgate.com

Bina Thompson 212-310-3072Hope Spiller 212-310-2291

Copyright Business Wire 2009


Related Shares:

CLG.L
FTSE 100 Latest
Value8,463.46
Change46.12